These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 5329700)
1. Effects of sparteine sulfate on uterine activity. Alexander JA; Franklin RR Tex Med; 1966 Aug; 62(8):54-6. PubMed ID: 5329700 [No Abstract] [Full Text] [Related]
2. Influence of sparteine sulphate on bioelectrical activity of the myometrium in pregnancy. Bialas E; Pydzik T; Gielwanowski W Mater Med Pol; 1972; 4(3):135-9. PubMed ID: 4664415 [No Abstract] [Full Text] [Related]
3. A comparative study of acceleration of labour by sparteine sulphate and oxytocin. Kishore N; Puspa MS J Indian Med Assoc; 1969 May; 52(10):449-53. PubMed ID: 5798964 [No Abstract] [Full Text] [Related]
4. [The action of an antispastic-antidystonic drug on cervical dystocia during labor]. Mistò A Ann Ostet Ginecol Med Perinat; 1967 Jun; 89(6):412-23. PubMed ID: 5607663 [No Abstract] [Full Text] [Related]
5. [Oxytocin tablets for the induction and stimulation of labor. A clinical evaluation of 100 cases]. Harry JM Ugeskr Laeger; 1966 Mar; 128(12):345-8. PubMed ID: 5915751 [No Abstract] [Full Text] [Related]
8. [Transbuccal application of oxytocin (syntocinon) and an oxytocin derivative (deamino-oxytocin-ODA 914-Sandoz]. Berger M Praxis; 1968 Apr; 57(17):588-94. PubMed ID: 5756153 [No Abstract] [Full Text] [Related]
9. [Our acquisitions and results with 1-(alpha-thienyl)-1-phenyl-3-(N-methyl-morpholino)-1-propanol iodide (TE 114) in the treatment of abnormally painful and prolonged labor]. Zanoner C Friuli Med; 1968; 23(4):629-41. PubMed ID: 5720903 [No Abstract] [Full Text] [Related]
10. [Sparteine sulfate as an oxytocic agent. Clinical considerations on its use during a 3-year period]. Colombo PA Attual Ostet Ginecol; 1967; 12(5):385-401. PubMed ID: 5616111 [No Abstract] [Full Text] [Related]
11. [Uterotropic effect of desamino-oxytocin (ODA 914) in oral administration]. Crevoisier P; Berger M Praxis; 1968 Apr; 57(17):578-87. PubMed ID: 5756152 [No Abstract] [Full Text] [Related]
12. Policies for labour management--existence and content. Stålhammar A; Boström B Scand J Caring Sci; 2008 Jun; 22(2):259-64. PubMed ID: 18489697 [TBL] [Abstract][Full Text] [Related]
13. [The use of prostaglandins in atonic uterine hemorrhages following vaginal delivery]. Paskaleva V; Milchev N; Velchev G; Pekhlivanov B Akush Ginekol (Sofiia); 2000; 39(2):10-1. PubMed ID: 10948611 [TBL] [Abstract][Full Text] [Related]
14. [Fetal mortality in labor with breech presentation. Statistical study; value of perfusions of oxytocics]. Palliez R; Delecour M; Monnier JC; Begueri F Gynecol Obstet (Paris); 1967; 66(3):283-92. PubMed ID: 6079447 [No Abstract] [Full Text] [Related]
15. SPARTEINE SULFATE: A CLINICAL EVALUATION OF ITS USE IN 100 CASES. STUBBLEFIELD CT; BARLOON JH; KELTNER RO Obstet Gynecol; 1963 Sep; 22():341-5. PubMed ID: 14065508 [No Abstract] [Full Text] [Related]
16. [Drug administration during labor]. Warm R Z Arztl Fortbild (Jena); 1966 Jun; 60(11):657-61. PubMed ID: 5994870 [No Abstract] [Full Text] [Related]
17. [Tokofinal, a new preparation with a substance synergistic with oxytocic drugs]. ROBECCHI E Minerva Ginecol; 1955 Jun; 7(12):149-50. PubMed ID: 13253345 [No Abstract] [Full Text] [Related]
18. [Changes in the phosphorus compound and electrolyte content of the blood during pregnancy and labor under the effect of drugs with tonomotoric action: vetrasine and ATP]. Matspanova OD; Vlasova LI; Koroleva AM; Sidorova IS Vopr Okhr Materin Det; 1972 Sep; 17(9):70-3. PubMed ID: 4655234 [No Abstract] [Full Text] [Related]